Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice

Elena Palma, Tania Tiepolo, Alessia Angelin, Patrizia Sabatelli, Nadir M. Maraldi, Emy Basso, Michael Forte, Paolo Bernardip, Paolo Bonaldo

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy are inherited muscle disorders caused by mutations of genes encoding the extracellular matrix protein collagen VI (ColVI). Mice lacking ColVI (Col6a1-/-) display a myopathic phenotype associated with ultrastructural alterations of mitochondria and sarcoplasmic reticulum, mitochondrial dysfunction with abnormal opening of the permeability transition pore (PTP) and increased apoptosis of muscle fibers. Treatment with cyclosporin (Cs) A, a drug that desensitizes the PTP by binding to cyclophilin (Cyp)-D, was shown to rescue myofiber alterations in (Col6a1-/-) mice and in UCMD patients, suggesting a correlation between PTP opening and pathogenesis of ColVI muscular dystrophies. Here, we show that inactivation of the gene encoding for Cyp-D rescues the disease phenotype of ColVI deficiency. In the absence of Cyp-D, Col6a1-/- mice show negligible myofiber degeneration, rescue from mitochondrial dysfunction and ultrastructural defects, and normalized incidence of apoptosis. These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent PTP regulation and pathogenesis of the ColVI muscular dystrophy and (iii) validate Cyp-D and the PTP as pharmacological targets for the therapy of human ColVI myopathies.

Original languageEnglish (US)
Pages (from-to)2024-2031
Number of pages8
JournalHuman Molecular Genetics
Volume18
Issue number11
DOIs
StatePublished - 2009

Fingerprint

Collagen
Permeability
Apoptosis
Muscles
Muscular Dystrophies
Muscular Diseases
Phenotype
Collagen Diseases
Extracellular Matrix Proteins
Sarcoplasmic Reticulum
Gene Silencing
Cyclosporine
cyclophilin D
Mitochondria
Pharmacology
Mutation
Incidence
Therapeutics
Pharmaceutical Preparations
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Palma, E., Tiepolo, T., Angelin, A., Sabatelli, P., Maraldi, N. M., Basso, E., ... Bonaldo, P. (2009). Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Human Molecular Genetics, 18(11), 2024-2031. https://doi.org/10.1093/hmg/ddp126

Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. / Palma, Elena; Tiepolo, Tania; Angelin, Alessia; Sabatelli, Patrizia; Maraldi, Nadir M.; Basso, Emy; Forte, Michael; Bernardip, Paolo; Bonaldo, Paolo.

In: Human Molecular Genetics, Vol. 18, No. 11, 2009, p. 2024-2031.

Research output: Contribution to journalArticle

Palma, E, Tiepolo, T, Angelin, A, Sabatelli, P, Maraldi, NM, Basso, E, Forte, M, Bernardip, P & Bonaldo, P 2009, 'Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice', Human Molecular Genetics, vol. 18, no. 11, pp. 2024-2031. https://doi.org/10.1093/hmg/ddp126
Palma, Elena ; Tiepolo, Tania ; Angelin, Alessia ; Sabatelli, Patrizia ; Maraldi, Nadir M. ; Basso, Emy ; Forte, Michael ; Bernardip, Paolo ; Bonaldo, Paolo. / Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. In: Human Molecular Genetics. 2009 ; Vol. 18, No. 11. pp. 2024-2031.
@article{330aa78a22114a80bec0041cc5b5a282,
title = "Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice",
abstract = "Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy are inherited muscle disorders caused by mutations of genes encoding the extracellular matrix protein collagen VI (ColVI). Mice lacking ColVI (Col6a1-/-) display a myopathic phenotype associated with ultrastructural alterations of mitochondria and sarcoplasmic reticulum, mitochondrial dysfunction with abnormal opening of the permeability transition pore (PTP) and increased apoptosis of muscle fibers. Treatment with cyclosporin (Cs) A, a drug that desensitizes the PTP by binding to cyclophilin (Cyp)-D, was shown to rescue myofiber alterations in (Col6a1-/-) mice and in UCMD patients, suggesting a correlation between PTP opening and pathogenesis of ColVI muscular dystrophies. Here, we show that inactivation of the gene encoding for Cyp-D rescues the disease phenotype of ColVI deficiency. In the absence of Cyp-D, Col6a1-/- mice show negligible myofiber degeneration, rescue from mitochondrial dysfunction and ultrastructural defects, and normalized incidence of apoptosis. These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent PTP regulation and pathogenesis of the ColVI muscular dystrophy and (iii) validate Cyp-D and the PTP as pharmacological targets for the therapy of human ColVI myopathies.",
author = "Elena Palma and Tania Tiepolo and Alessia Angelin and Patrizia Sabatelli and Maraldi, {Nadir M.} and Emy Basso and Michael Forte and Paolo Bernardip and Paolo Bonaldo",
year = "2009",
doi = "10.1093/hmg/ddp126",
language = "English (US)",
volume = "18",
pages = "2024--2031",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice

AU - Palma, Elena

AU - Tiepolo, Tania

AU - Angelin, Alessia

AU - Sabatelli, Patrizia

AU - Maraldi, Nadir M.

AU - Basso, Emy

AU - Forte, Michael

AU - Bernardip, Paolo

AU - Bonaldo, Paolo

PY - 2009

Y1 - 2009

N2 - Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy are inherited muscle disorders caused by mutations of genes encoding the extracellular matrix protein collagen VI (ColVI). Mice lacking ColVI (Col6a1-/-) display a myopathic phenotype associated with ultrastructural alterations of mitochondria and sarcoplasmic reticulum, mitochondrial dysfunction with abnormal opening of the permeability transition pore (PTP) and increased apoptosis of muscle fibers. Treatment with cyclosporin (Cs) A, a drug that desensitizes the PTP by binding to cyclophilin (Cyp)-D, was shown to rescue myofiber alterations in (Col6a1-/-) mice and in UCMD patients, suggesting a correlation between PTP opening and pathogenesis of ColVI muscular dystrophies. Here, we show that inactivation of the gene encoding for Cyp-D rescues the disease phenotype of ColVI deficiency. In the absence of Cyp-D, Col6a1-/- mice show negligible myofiber degeneration, rescue from mitochondrial dysfunction and ultrastructural defects, and normalized incidence of apoptosis. These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent PTP regulation and pathogenesis of the ColVI muscular dystrophy and (iii) validate Cyp-D and the PTP as pharmacological targets for the therapy of human ColVI myopathies.

AB - Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy are inherited muscle disorders caused by mutations of genes encoding the extracellular matrix protein collagen VI (ColVI). Mice lacking ColVI (Col6a1-/-) display a myopathic phenotype associated with ultrastructural alterations of mitochondria and sarcoplasmic reticulum, mitochondrial dysfunction with abnormal opening of the permeability transition pore (PTP) and increased apoptosis of muscle fibers. Treatment with cyclosporin (Cs) A, a drug that desensitizes the PTP by binding to cyclophilin (Cyp)-D, was shown to rescue myofiber alterations in (Col6a1-/-) mice and in UCMD patients, suggesting a correlation between PTP opening and pathogenesis of ColVI muscular dystrophies. Here, we show that inactivation of the gene encoding for Cyp-D rescues the disease phenotype of ColVI deficiency. In the absence of Cyp-D, Col6a1-/- mice show negligible myofiber degeneration, rescue from mitochondrial dysfunction and ultrastructural defects, and normalized incidence of apoptosis. These findings (i) demonstrate that lack of Cyp-D is equivalent to its inhibition with CsA at curing the mouse dystrophic phenotype; (ii) establish a cause-effect relationship between Cyp-D-dependent PTP regulation and pathogenesis of the ColVI muscular dystrophy and (iii) validate Cyp-D and the PTP as pharmacological targets for the therapy of human ColVI myopathies.

UR - http://www.scopus.com/inward/record.url?scp=65549087972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549087972&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddp126

DO - 10.1093/hmg/ddp126

M3 - Article

VL - 18

SP - 2024

EP - 2031

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 11

ER -